The Relevance of Regenerating Gene 1a Polymorphisms to Radiation Sensitivity and Survival of Nasopharyngeal Carcinoma Receiving Radiotherapy in a Southern Chinese Population.

Pharmacogenomics and Personalized Medicine Pub Date : 2021-11-06 eCollection Date: 2021-01-01 DOI:10.2147/PGPM.S328285
Hai-Jie Xing, Xiang-Dong Chen, Hong-Xia Sun, Yao-Zhang Dai, Yao-Feng Han, Hai-Bo Chen, Feng Liu
{"title":"The Relevance of Regenerating Gene 1a Polymorphisms to Radiation Sensitivity and Survival of Nasopharyngeal Carcinoma Receiving Radiotherapy in a Southern Chinese Population.","authors":"Hai-Jie Xing,&nbsp;Xiang-Dong Chen,&nbsp;Hong-Xia Sun,&nbsp;Yao-Zhang Dai,&nbsp;Yao-Feng Han,&nbsp;Hai-Bo Chen,&nbsp;Feng Liu","doi":"10.2147/PGPM.S328285","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Gene polymorphism is closely related to tumor development, therapeutic response and prognosis. The relationship between regenerating gene 1A (Reg1A) polymorphism and nasopharyngeal carcinoma (NPC) is unclear. This retrospective study aimed to analyze the association between Reg1a polymorphisms and metastasis, radiation sensitivity and survivals in patients with NPC.</p><p><strong>Methods: </strong>A total of 308 patients who had received radiotherapy at the Affiliated Xinhua Hospital, Hainan Medical College, between January 2010 and December 2018 with NPC, were enrolled for assessment of Reg1a polymorphisms through direct DNA sequencing.</p><p><strong>Results: </strong>In the polymorphism of gene REG1A, patients with rs10165462 20CC genotype had later T stages (OR = 4.051, 95% CI: 1.775-9.244, P = 0.001), whereas carriers with rs12072 2922CC genotype had earlier T stages (OR = 1.891, 95% CI: 1.018-3.514, P = 0.044) after adjustments for age and gender, respectively. Among rs10165462 20 C/T polymorphism, 20TT wild-type was associated with better radiation response (P = 0.0019), and multivariate analysis showed that it was the only genotype of polymorphism that was significantly associated with better radiation response (OR = 0.265, 95% CI: 0.096-0.727, P = 0.01). Patients with the 20TT wild-type had a better five-year overall survival (60.9%) rate and five-year progression-free survival (60.8%) than those with the 20CC genotype (41.8% and 39.4%, P = 0.01 and P = 0.004, respectively). Patients with variant alleles (CC + CT) had significantly poorer OS (45.2%) and PFS (41.8%) compared with wild-type (TT) carriers (60.9% and 60.8%; P = 0.037 and P = 0.015, respectively). As for rs12072, patients with variant alleles (TT + TC) had significantly adverse OS and PFS compared with wild-type (CC) carriers (62.5% vs 44.8% and 62.5% vs 42.9%; P = 0.024 and P = 0.027, respectively). Cox regression showed that rs10165462 20CT was the only prognostic factor for OS (HR = 1.642, 95% CI 1.038-2.598, P = 0.034) and PFS (HR = 1.705, 95% CI 1.080-2.692, P = 0.022).</p><p><strong>Conclusion: </strong>Reg1a polymorphisms may be a predictor of radiation response, local invasion, OS and PFS in patients with NPC who undergo radiotherapy treatment.</p>","PeriodicalId":509088,"journal":{"name":"Pharmacogenomics and Personalized Medicine","volume":" ","pages":"1403-1413"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/f3/pgpm-14-1403.PMC8579874.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics and Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PGPM.S328285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Gene polymorphism is closely related to tumor development, therapeutic response and prognosis. The relationship between regenerating gene 1A (Reg1A) polymorphism and nasopharyngeal carcinoma (NPC) is unclear. This retrospective study aimed to analyze the association between Reg1a polymorphisms and metastasis, radiation sensitivity and survivals in patients with NPC.

Methods: A total of 308 patients who had received radiotherapy at the Affiliated Xinhua Hospital, Hainan Medical College, between January 2010 and December 2018 with NPC, were enrolled for assessment of Reg1a polymorphisms through direct DNA sequencing.

Results: In the polymorphism of gene REG1A, patients with rs10165462 20CC genotype had later T stages (OR = 4.051, 95% CI: 1.775-9.244, P = 0.001), whereas carriers with rs12072 2922CC genotype had earlier T stages (OR = 1.891, 95% CI: 1.018-3.514, P = 0.044) after adjustments for age and gender, respectively. Among rs10165462 20 C/T polymorphism, 20TT wild-type was associated with better radiation response (P = 0.0019), and multivariate analysis showed that it was the only genotype of polymorphism that was significantly associated with better radiation response (OR = 0.265, 95% CI: 0.096-0.727, P = 0.01). Patients with the 20TT wild-type had a better five-year overall survival (60.9%) rate and five-year progression-free survival (60.8%) than those with the 20CC genotype (41.8% and 39.4%, P = 0.01 and P = 0.004, respectively). Patients with variant alleles (CC + CT) had significantly poorer OS (45.2%) and PFS (41.8%) compared with wild-type (TT) carriers (60.9% and 60.8%; P = 0.037 and P = 0.015, respectively). As for rs12072, patients with variant alleles (TT + TC) had significantly adverse OS and PFS compared with wild-type (CC) carriers (62.5% vs 44.8% and 62.5% vs 42.9%; P = 0.024 and P = 0.027, respectively). Cox regression showed that rs10165462 20CT was the only prognostic factor for OS (HR = 1.642, 95% CI 1.038-2.598, P = 0.034) and PFS (HR = 1.705, 95% CI 1.080-2.692, P = 0.022).

Conclusion: Reg1a polymorphisms may be a predictor of radiation response, local invasion, OS and PFS in patients with NPC who undergo radiotherapy treatment.

Abstract Image

再生基因1a多态性与中国南方鼻咽癌放疗患者放疗敏感性和生存率的相关性
目的:基因多态性与肿瘤的发展、治疗反应及预后密切相关。再生基因1A (Reg1A)多态性与鼻咽癌(NPC)的关系尚不清楚。本回顾性研究旨在分析Reg1a多态性与鼻咽癌患者的转移、放射敏感性和生存之间的关系。方法:选取2010年1月至2018年12月在海南医学院附属新华医院接受放疗的NPC患者308例,通过直接DNA测序评估Reg1a多态性。结果:REG1A基因多态性中,rs10165462 20CC基因型患者T分期较晚(OR = 4.051, 95% CI: 1.75 75 ~ 9.244, P = 0.001), rs12072 2922CC基因型患者T分期较早(OR = 1.891, 95% CI: 1.018 ~ 3.514, P = 0.044)。在rs10165462 20 C/T多态性中,20TT野生型与较好的放射反应相关(P = 0.0019),多因素分析显示,20TT野生型是唯一与较好的放射反应显著相关的多态性基因型(OR = 0.265, 95% CI: 0.096 ~ 0.727, P = 0.01)。20TT野生型患者的5年总生存率(60.9%)和5年无进展生存率(60.8%)分别高于20CC基因型患者(41.8%和39.4%,P = 0.01和P = 0.004)。变异等位基因(CC + CT)患者的OS(45.2%)和PFS(41.8%)明显低于野生型(TT)携带者(60.9%和60.8%;P = 0.037和P = 0.015)。对于rs12072,与野生型(CC)携带者相比,携带变异等位基因(TT + TC)的患者的OS和PFS明显不良(62.5% vs 44.8%, 62.5% vs 42.9%;P = 0.024, P = 0.027)。Cox回归显示rs10165462 20CT是OS (HR = 1.642, 95% CI 1.038 ~ 2.598, P = 0.034)和PFS (HR = 1.705, 95% CI 1.080 ~ 2.692, P = 0.022)的唯一预后因素。结论:Reg1a多态性可能是鼻咽癌放疗患者放射反应、局部侵袭、OS和PFS的预测因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书